{"id":"clindamycin-dexamethasone","safety":{"commonSideEffects":[{"rate":null,"effect":"Diarrhea (clindamycin-associated)"},{"rate":null,"effect":"Pseudomembranous colitis"},{"rate":null,"effect":"Hyperglycemia (dexamethasone)"},{"rate":null,"effect":"Immunosuppression"},{"rate":null,"effect":"Insomnia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clindamycin is a lincosamide antibiotic that binds to bacterial 50S ribosomal subunits to inhibit protein synthesis, effective against anaerobic and gram-positive organisms. Dexamethasone is a potent corticosteroid that reduces inflammation by suppressing immune cell activation and cytokine production. The combination targets both infection and inflammatory complications.","oneSentence":"Clindamycin inhibits bacterial protein synthesis while dexamethasone suppresses inflammation and immune response, combining antimicrobial and anti-inflammatory effects.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:06:19.117Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Severe bacterial infections with significant inflammatory component (Phase 3 investigational)"}]},"trialDetails":[{"nctId":"NCT04278404","phase":"","title":"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-03-05","conditions":"Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children","enrollment":5000},{"nctId":"NCT04341155","phase":"PHASE2","title":"Dexamethasone for Cerebral Toxoplasmosis","status":"RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2021-04-16","conditions":"Toxoplasmosis, Cerebral","enrollment":138},{"nctId":"NCT05099055","phase":"PHASE3","title":"Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study","status":"COMPLETED","sponsor":"St. Justine's Hospital","startDate":"2022-03-15","conditions":"Analgesia, Analgesics, Opioid, Anesthesia, Obstetrical","enrollment":42},{"nctId":"NCT04118296","phase":"PHASE1, PHASE2","title":"Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream","status":"COMPLETED","sponsor":"Sukma Skin Treatment","startDate":"2019-10-08","conditions":"Acne Vulgaris","enrollment":150},{"nctId":"NCT00372294","phase":"PHASE3","title":"To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2005-07","conditions":"Chorioretinitis","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Clindamycin+Dexamethasone","genericName":"Clindamycin+Dexamethasone","companyName":"Shahid Beheshti University of Medical Sciences","companyId":"shahid-beheshti-university-of-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clindamycin is a small molecule that inhibits the bacterial 70S ribosome, classified as an inhibitor. It is used in combination with dexamethasone for various conditions, including cerebral toxoplasmosis, as seen in clinical trials such as NCT04341155.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}